BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16574657)

  • 1. Specific regulation of IRS-2 expression by glucose in rat primary pancreatic islet beta-cells.
    Lingohr MK; Briaud I; Dickson LM; McCuaig JF; Alárcon C; Wicksteed BL; Rhodes CJ
    J Biol Chem; 2006 Jun; 281(23):15884-92. PubMed ID: 16574657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific glucose-induced control of insulin receptor substrate-2 expression is mediated via Ca2+-dependent calcineurin/NFAT signaling in primary pancreatic islet β-cells.
    Demozay D; Tsunekawa S; Briaud I; Shah R; Rhodes CJ
    Diabetes; 2011 Nov; 60(11):2892-902. PubMed ID: 21940781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific increased expression of insulin receptor substrate 2 in pancreatic beta-cell lines is involved in mediating serum-stimulated beta-cell growth.
    Schuppin GT; Pons S; Hügl S; Aiello LP; King GL; White M; Rhodes CJ
    Diabetes; 1998 Jul; 47(7):1074-85. PubMed ID: 9648831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells.
    Briaud I; Dickson LM; Lingohr MK; McCuaig JF; Lawrence JC; Rhodes CJ
    J Biol Chem; 2005 Jan; 280(3):2282-93. PubMed ID: 15537654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of glucose in IRS signaling in rat pancreatic islets: specific effects and interplay with insulin.
    Paris M; Bernard-Kargar C; Vilar J; Kassis N; Ktorza A
    Exp Diabesity Res; 2004; 5(4):257-63. PubMed ID: 15763940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.
    Lingohr MK; Dickson LM; McCuaig JF; Hugl SR; Twardzik DR; Rhodes CJ
    Diabetes; 2002 Apr; 51(4):966-76. PubMed ID: 11916914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose- and insulin-induced phosphorylation of the insulin receptor and its primary substrates IRS-1 and IRS-2 in rat pancreatic islets.
    Velloso LA; Carneiro EM; Crepaldi SC; Boschero AC; Saad MJ
    FEBS Lett; 1995 Dec; 377(3):353-7. PubMed ID: 8549754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells.
    Porzio O; Federici M; Hribal ML; Lauro D; Accili D; Lauro R; Borboni P; Sesti G
    J Clin Invest; 1999 Aug; 104(3):357-64. PubMed ID: 10430617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GTK tyrosine kinase-induced alteration of IRS-protein signalling in insulin producing cells.
    Annerén C; Welsh M
    Mol Med; 2002 Nov; 8(11):705-13. PubMed ID: 12520087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRS-3 inhibits IRS-2-mediated signaling in pancreatic beta-cells.
    Lingohr MK; Dickson LM; Wrede CE; McCuaig JF; Myers MG; Rhodes CJ
    Mol Cell Endocrinol; 2003 Jun; 204(1-2):85-99. PubMed ID: 12850284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreasing IRS-2 expression in pancreatic beta-cells (INS-1) promotes apoptosis, which can be compensated for by introduction of IRS-4 expression.
    Lingohr MK; Dickson LM; Wrede CE; Briaud I; McCuaig JF; Myers MG; Rhodes CJ
    Mol Cell Endocrinol; 2003 Nov; 209(1-2):17-31. PubMed ID: 14604813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of insulin secretion in pancreatic islets of protein-deficient rats by reduced expression of insulin receptor substrate (IRS)-1 and IRS-2.
    Araujo EP; Amaral ME; Filiputti E; De Souza CT; Laurito TL; Augusto VD; Saad MJ; Boschero AC; Velloso LA; Carneiro EM
    J Endocrinol; 2004 Apr; 181(1):25-38. PubMed ID: 15072564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
    Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
    Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin receptor substrate 1-induced inhibition of endoplasmic reticulum Ca2+ uptake in beta-cells. Autocrine regulation of intracellular ca2+ homeostasis and insulin secretion.
    Xu GG; Gao ZY; Borge PD; Wolf BA
    J Biol Chem; 1999 Jun; 274(25):18067-74. PubMed ID: 10364259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the Shb SH2 domain-protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins.
    Welsh N; Makeeva N; Welsh M
    Mol Med; 2002 Nov; 8(11):695-704. PubMed ID: 12520086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin-signal transduction in neonatal rat pancreatic islets and interaction with the insulin-signaling pathway.
    Amaral ME; Ueno M; Carvalheira JB; Carneiro EM; Velloso LA; Saad MJ; Boschero AC
    Horm Metab Res; 2003 May; 35(5):282-9. PubMed ID: 12915997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells.
    Hennige AM; Ozcan U; Okada T; Jhala US; Schubert M; White MF; Kulkarni RN
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E337-46. PubMed ID: 15827066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet beta-cells.
    Harbeck MC; Louie DC; Howland J; Wolf BA; Rothenberg PL
    Diabetes; 1996 Jun; 45(6):711-7. PubMed ID: 8635642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone reverses insulin secretion altered by chronic exposure to free fatty acid via IRS-2-associated phosphatidylinositol 3-kinase pathway.
    Yang L; An HX; Deng XL; Chen LL; Li ZY
    Acta Pharmacol Sin; 2003 May; 24(5):429-34. PubMed ID: 12740178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.